Swiss-based pharmaceuticals giant Novartis said Monday it was acquiring Selexys Pharmaceuticals Corp., a US research lab in blood and inflammatory disorders, in a deal costing up to $665 million (627 million euros).
Nov 21, 2016
0
0
A new study led by Indiana University School of Medicine researchers has found that a brain network condition called "explosive synchronization" could be the cause of extreme pain crises in people with sickle cell disease.
Apr 24, 2024
0
28
The gene editing technique CRISPR has been making headlines worldwide for its potential to change the genetic makeup of organisms and treat genetic diseases such as sickle cell anemia. It has vast potential in many areas—including ...
Apr 23, 2021
0
4
Adults stop anti-rejection drugs after stem-cell transplant reverses sickle cell disease NIH trial success suggests a new treatment option for older, sicker patients
Jul 1, 2014
0
0
The pain from a heart attack is so bad that—if you can imagine—it can feel like an elephant sitting on you. Patients with sickle cell disease, a genetic condition affecting the red blood cells, report that this kind of ...
Sep 18, 2023
0
1
Sickle cell disease is characterized by recurrent episodes of "sickle crisis," also known as vaso-occlusive crisis, in which a patient's red blood cells change shape, clump together and block the flow of blood in small vessels ...
Feb 1, 2017
0
0
From the start of the coronavirus pandemic, there has been an attempt to use science to explain the disproportionate impact of COVID-19 on different groups through the prism of race. Data from the UK and the US suggests that ...
May 28, 2020
0
8
Few youths with sickle cell anemia (SCA) receive hydroxyurea despite national guidelines recommending its use, according to a study published online March 24 in JAMA Network Open.
Mar 28, 2023
0
0
New research has shown that boosting the "warm glow" feeling that people experience after giving blood significantly increases repeat blood donations, which are essential for the effective running of any health service.
Sep 14, 2023
0
25
Vanderbilt University Medical Center (VUMC) researchers are touting data from a multicenter, international Phase II clinical trial showing a new, curative treatment for sickle cell disease (SCD).
Jun 26, 2024
0
8
